Long-term survival analysis of cancer patients after treatment
Studies on Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Fudan University Shanghai Cancer Center Registry（FUCaRe）
This study looks at how well cancer patients do over the long term after different treatments to see what factors affect their survival.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500000 (estimated) |
| Sex | All |
| Sponsor | Fudan University Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 1 site (Shanghai) |
| Trial ID | NCT04996732 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on the long-term prognosis of patients with malignant tumors who received various anti-tumor treatments at Fudan University Shanghai Cancer Center. It involves continuous enrollment of patients and tracks overall and disease-free survival rates through medical record reviews, telephone interviews, and data linkage to provincial death registries. The study aims to generate real-world data on cancer survivorship and explore determinants of survival from both clinical and socio-economic perspectives.
Who should consider this trial
Good fit: Ideal candidates include patients who have completed treatment for malignant tumors at Fudan University Shanghai Cancer Center.
Not a fit: Patients who have not undergone treatment during hospitalization or those with non-malignant tumors may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term survival rates of cancer patients, potentially guiding future treatment approaches.
How similar studies have performed: Other studies have shown success in analyzing long-term cancer survivorship, making this approach both relevant and valuable.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients who completed tumor treatment (including surgery, radiotherapy, chemotherapy, immunotherapy, etc.) due to malignant tumors based on preoperative or intraoperative evaluation in Fudan University Shanghai Cancer Center during the study period. Exclusion Criteria: * Patients who have not been treated during hospitalization; * Patients with non-malignant tumors.
Where this trial is running
Shanghai
- Fudan University Shanghai Cancer Center — Shanghai, China (Recruiting)
Study contacts
- Study coordinator: Ying Zheng, Dr.
- Email: zhengying@fudan.edu.cn
- Phone: +8618121299522
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.